Atlas Arteria shares: Q4 2025 toll revenue jumps 9.5%

The Atlas Arteria Ltd (ASX: ALX) share price is in focus today after the company reported Q4 2025 proportionate toll revenue up 9.5% on last year, with full-year revenue also climbing 9.4% thanks to steady traffic and higher tolls across key assets.

What did Atlas Arteria report?

• Q4 2025 proportionate toll revenue rose 9.5% compared to Q4 2024
• Full-year 2025 proportionate toll revenue increased 9.4% year-on-year
• APRR quarterly revenue up 1.5%, annual revenue up 2.8% (EUR terms)
• Chicago Skyway quarterly toll revenue up 10%, annual up 6.2% (USD terms)
• Traffic rose on Dulles Greenway (Q4 up 4.8%; year up 8.2%), and A79 (Q4 up 7.5%; year up 10.5%)
• Warnow Tunnel traffic fell 9.8% in Q4, revenue down 5.6% (EUR terms)

What else do investors need to know?

Steady economic conditions in France and a recovery in cross-border work permits to Geneva helped drive light vehicle traffic on major French assets. The company noted robust commuter flows, with Swiss permits up 2.9% for Geneva in the September quarter.

In the US, Chicago Skyway saw a bounce-back in both light and heavy vehicle usage after the prior period’s roadworks and tariff announcements. Dulles Greenway overcame disruptions from a six-week US federal government shutdown, returning to pre-shutdown traffic growth.

Toll revenue growth benefited from toll price increases across most businesses as well as favourable foreign exchange movements. On a constant currency basis, proportionate toll revenue grew around 2.2% for Q4 and 3.0% for the full year.

What’s next for Atlas Arteria?

Atlas Arteria continues to focus on disciplined management of its international toll road assets, with plans to leverage network upgrades, pricing, and customer service enhancements. The business emphasises operational efficiency and sustainable practices across its European and North American assets.

Looking ahead, the company aims to drive value by responding to regional traffic patterns, optimising toll structures, and adapting to changing commuter needs, including ongoing infrastructure maintenance and upgrades.

Atlas Arteria share price snapshot

Over the past 12 months, Altas Arteria shares have declined 1%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 5% over the same period.

View Original Announcement

The post Atlas Arteria shares: Q4 2025 toll revenue jumps 9.5% appeared first on The Motley Fool Australia.

More reading

• Elders FY25 earnings: resilient profit and strategic growth
• Resmed posts Q2 FY26 earnings growth, lifts dividend
• Nine Entertainment shakes up portfolio: QMS buy, radio sale, and digital focus
• PLS Group books 49% revenue leap and strong cash flow in December quarter earnings
• The high flying ASX small-cap AI stock you need to pay attention to!

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.